about
HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmissionPhylodynamic analysis of HIV sub-epidemics in Mochudi, BotswanaHIV-1 subtype C in vitro growth and coreceptor utilization.Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infectionBetter control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCTHIV-1 drug mutations in children from northern TanzaniaTransmission of single and multiple viral variants in primary HIV-1 subtype C infection.Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana.Vitamin D insufficiency in HIV-infected pregnant women receiving antiretroviral therapy is not associated with morbidity, mortality or growth impairment in their uninfected infants in Botswana.Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.Phylogenetic relatedness of circulating HIV-1C variants in Mochudi, BotswanaAn augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trialImmune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity.Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancyPrevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in BotswanaPrevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana.Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in BotswanaValidation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In BotswanaLength of secondary schooling and risk of HIV infection in Botswana: evidence from a natural experiment.Infant feeding practices were not associated with breast milk HIV-1 RNA levels in a randomized clinical trial in Botswana.Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infectionHigh viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.Intra-host evolutionary rates in HIV-1C env and gag during primary infection.No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable.Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.Training-of-trainers: A strategy to build country capacity for SLMTA expansion and sustainability.Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana.Importance of Viral Sequence Length and Number of Variable and Informative Sites in Analysis of HIV Clustering.Impact of sampling density on the extent of HIV clustering.Old plants newly discovered: Cassia sieberiana D.C. and Cassia abbreviata Oliv. Oliv. root extracts inhibit in vitro HIV-1c replication in peripheral blood mononuclear cells (PBMCs) by different modes of action.
P50
Q28473637-B62C1987-AD65-4773-986E-B0FFD05A22A5Q28606881-3070E200-7B84-46E7-AC49-0CB72228B416Q30352511-57EB616B-7EE2-4C2F-9A0F-2DB6FF1F61BBQ33515034-9565D1E6-87DC-4C8B-BFCF-8518FB9448B4Q33625545-4BC1E343-F551-421E-88F9-7F8195AE1649Q33686897-6C64415E-D6BB-490D-92FF-218131C96084Q33746054-FF4AD5F7-201B-4CD5-9FF2-B2EE833B0043Q33849796-EBD2270C-6E37-4C5E-8F06-3944BE054814Q33887266-A3767D06-215C-463A-8882-936F70540ECBQ34437771-4C2CAC3E-6C61-4E2B-A165-BBCA54D522CFQ34732899-B24131EB-5E53-4B00-8313-9C604B61C648Q34927469-316D6459-B51E-4363-9C17-2ECB57D101B9Q35037981-55715ABD-5B88-42A7-BBE5-13A2EF540D21Q35069391-C6C52311-3A9D-4BF5-9158-22EDF3B69586Q35101541-EB1A0EF9-8747-4913-BC95-1DCFCE1B40B3Q35127830-AA32BF62-B0B6-46A3-BAD0-42AE0B09DEDFQ35129403-28F7967F-80F6-4386-87D3-2647734CC27CQ35164233-D4C3E02F-34F8-4EEE-BA56-A0BCED7E3399Q35386228-C7E0736D-FBF3-420D-BDD4-7F824C072004Q35744379-C1972420-E2C2-4943-8D5B-C5ADA0B8DBA2Q35964202-BA7AB245-2695-41B6-83F9-082A1C4F9883Q36110367-547328B6-1C91-49E1-8F54-6AB5B6DD98BBQ36329990-7150F8F4-4C90-4F65-9DF1-30A41CC7CE82Q36365683-81AFEB33-DE13-4D49-9631-E11B901E7628Q36470674-E960F479-F80E-4F90-8A4D-6459DCE47985Q36842077-10FD1E59-30D4-4216-BC3C-8192C9044973Q36930454-6E0F0221-1B13-423C-80CA-F2AF33445FDAQ36937881-EB7706BD-03F3-4F4F-8511-A1ABFDFE0656Q37138341-06FE8FE8-ED85-43C3-B91C-EF50619F0AE1Q37146865-C62DD3C4-4CA0-45B5-AA01-5734482307D1Q37240053-1BAA9F16-0764-4F6A-8550-4BD5BB9F75F9Q37434357-F3F08A42-0152-4A33-B492-BBBC3CFA13E9Q37460164-59D85EF9-B749-4810-A2DE-0F0D43F8B81DQ37703445-6F187BD9-1843-454E-8F97-D83A6524B9E7Q38436843-9B698CFC-84A5-4BC6-9E2C-4401315916E7Q38863646-F500A280-8CED-4918-BE0E-E787222058B8Q39588236-947AB68D-657C-4965-B759-9D9C8A420D64Q40501110-064C0264-5EBD-4D81-B014-0D89E1C13380Q40794836-68967590-C15C-4321-852E-8D0AEFC9D368Q40796940-FCF99326-BBF9-46D7-B1ED-79BE27048F95
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sikhulile Moyo
@ast
Sikhulile Moyo
@en
Sikhulile Moyo
@es
Sikhulile Moyo
@nl
type
label
Sikhulile Moyo
@ast
Sikhulile Moyo
@en
Sikhulile Moyo
@es
Sikhulile Moyo
@nl
prefLabel
Sikhulile Moyo
@ast
Sikhulile Moyo
@en
Sikhulile Moyo
@es
Sikhulile Moyo
@nl
P106
P31
P496
0000-0003-3821-4592